The Peruvian market is dominated by a few major players, but SMEs like D & M Pharma Peru SAC serve niche markets. The 2024-2025 market is characterized by:
For more information, interested parties can visit its official website: or follow the updates on its LinkedIn profile: D&M Pharma Perú .
It serves as the authorized representative in Peru for the commercialization of pharmaceutical products, medical devices, and sanitary products from Laboratorio Pablo Cassará (Argentina) and Laboratorio D&M Pharma (Chile) . d amp m pharma peru sac
The operational footprint of D&M Pharma Peru S.A.C. relies heavily on strategic regional alliances.
Established as an international expansion branch of the broader Chilean corporate entity, the company serves as a vital bridge in the South American pharmaceutical supply chain. By collaborating with esteemed global laboratories—most notably Argentina's Laboratorio Cassará —the firm ensures the Peruvian population has access to high-quality therapeutic respiratory, ophthalmic, and skincare options. Corporate History and Regional Expansion The Peruvian market is dominated by a few
D&M Pharma Peru SAC operates in a highly regulated industry, and as such, the company prioritizes regulatory compliance. The company adheres to all relevant Peruvian and international regulations, ensuring that its products and operations meet the highest standards of quality, safety, and efficacy.
: Formulations catering to severe atopic dermatitis, eczema, and skin inflammation. 2. Dermatological Care (Fouchard, Bailleul, and FeelDerm) The operational footprint of D&M Pharma Peru S
The company operates under stringent oversight from Peru's National Director of Medicines, Supplies, and Drugs (). To maintain its authorization as an official pharmaceutical importer and distributor (Droguería), D&M Pharma Peru S.A.C. strictly adheres to localized and international benchmarks: